title: Phenol 8% solution for the treatment of epidermal growth factor receptor inhibitor-induced periungual pyogenic granulomas.
authors.affiliation: Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy - gafabbro@unina.it.
authors.forename: L
authors.initials: L
authors.lastname: Panariello
authors.forename: G
authors.initials: G
authors.lastname: Caro
authors.forename: D
authors.initials: D
authors.lastname: Bianca
authors.forename: G
authors.initials: G
authors.lastname: Fabbrocini
mesh_terms: D000287:Administration, Topical; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000150:complications / Q000188:drug therapy; D002424:Caustics / Q000008:administration & dosage / Q000627:therapeutic use*; D002425:Cautery / Q000379:methods*; D066246:ErbB Receptors / Q000037:antagonists & inhibitors*; D005260:Female; D017789:Granuloma, Pyogenic / Q000139:chemically induced / Q000601:surgery*; D006801:Humans; D000077341:Lapatinib; D008875:Middle Aged; D009260:Nail Diseases / Q000139:chemically induced / Q000601:surgery*; D009363:Neoplasm Proteins / Q000037:antagonists & inhibitors*; D019800:Phenol / Q000008:administration & dosage / Q000627:therapeutic use*; D047428:Protein Kinase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D011799:Quinazolines / Q000009:adverse effects* / Q000627:therapeutic use; D014034:Toes
chemical_list: D000970:Antineoplastic Agents; D002424:Caustics; D009363:Neoplasm Proteins; D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D000077341:Lapatinib; D019800:Phenol; C512478:EGFR protein, human; D066246:ErbB Receptors